EyePoint, Inc. (EYPT)
4.875
-0.44
(-8.36%)
USD |
NASDAQ |
Aug 24, 16:00
4.89
+0.02
(+0.31%)
After-Hours: 20:00
EyePoint Total Assets (Quarterly) : 228.19M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 228.19M |
| March 31, 2026 | 288.22M |
| December 31, 2025 | 364.00M |
| September 30, 2025 | 251.70M |
| June 30, 2025 | 301.15M |
| March 31, 2025 | 362.56M |
| December 31, 2024 | 418.46M |
| September 30, 2024 | 300.92M |
| June 30, 2024 | 324.25M |
| March 31, 2024 | 329.25M |
| December 31, 2023 | 355.18M |
| September 30, 2023 | 160.04M |
| June 30, 2023 | 175.66M |
| March 31, 2023 | 154.59M |
| December 31, 2022 | 180.36M |
| September 30, 2022 | 220.49M |
| June 30, 2022 | 233.43M |
| March 31, 2022 | 244.56M |
| December 31, 2021 | 263.37M |
| September 30, 2021 | 168.25M |
| June 30, 2021 | 178.82M |
| March 31, 2021 | 187.14M |
| December 31, 2020 | 91.72M |
| September 30, 2020 | 76.79M |
| June 30, 2020 | 69.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 80.29M |
| December 31, 2019 | 72.97M |
| September 30, 2019 | 79.07M |
| June 30, 2019 | 91.33M |
| March 31, 2019 | 81.85M |
| December 31, 2018 | 78.17M |
| September 30, 2018 | 88.86M |
| June 30, 2018 | 71.67M |
| March 31, 2018 | 50.16M |
| June 30, 2017 | 18.68M |
| March 31, 2017 | 17.50M |
| December 31, 2016 | 19.75M |
| September 30, 2016 | 24.93M |
| June 30, 2016 | 31.62M |
| March 31, 2016 | 36.16M |
| December 31, 2015 | 23.95M |
| September 30, 2015 | 27.46M |
| June 30, 2015 | 32.37M |
| March 31, 2015 | 35.70M |
| December 31, 2014 | 40.18M |
| September 30, 2014 | 43.74M |
| June 30, 2014 | 22.67M |
| March 31, 2014 | 26.02M |
| December 31, 2013 | 20.82M |
| September 30, 2013 | 22.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 671.32M |
| Eli Lilly & Co. | 142.28B |
| Elanco Animal Health, Inc. | 13.56B |
| Amylyx Pharmaceuticals, Inc. | 264.56M |
| Nuvation Bio, Inc. | 744.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 61.78M |
| Shareholders Equity (Quarterly) | 166.41M |
| Debt to Equity Ratio | 0.1344 |
| Current Ratio | 4.502 |
| Net Debt Paydown Yield | 0.03% |